Definitive Radiotherapy With or Without Chemotherapy After Planned Neoadjuvant Chemoimmunotherapy in Stages II to III NSCLC: An International Multicenter Retrospective Study.

Saved in:
Bibliographic Details
Title: Definitive Radiotherapy With or Without Chemotherapy After Planned Neoadjuvant Chemoimmunotherapy in Stages II to III NSCLC: An International Multicenter Retrospective Study.
Authors: Adib E; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Radiation Oncology Program, Boston, Massachusetts., Nassar AH; Division of Oncology, Yale University School of Medicine, New Haven, Connecticut., Lee KN; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Fusco F; IRCCS Regina Elena National Cancer Institute, Rome, Italy., Crowley F; Division of Hematology-Oncology, Department of Medicine, Tisch Cancer Institute, Mount Sinai Hospital, New York, New York., Baena J; Division of Hematology-Oncology, Department of Medicine, Tisch Cancer Institute, Mount Sinai Hospital, New York, New York., Worth JE; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Abi Jaoude J; Department of Radiation Oncology, Stanford University, Stanford, California., Addeo A; Department of Oncology, University Hospital Geneva (HUG), Geneva, Switzerland., Bou Farhat E; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Rakaee M; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Amini A; Department of Radiation Oncology, City of Hope National Medical Center, Duarte, California., Lambden J; University of Colorado Cancer Center, Aurora, Colorado., Rost M; Department of Medicine II, Hematology, Oncology, University Hospital Frankfurt, Frankfurt am Main, Frankfurt, Germany., Bolnykh I; Department of Oncology, Chelsea and Westminster NHS Foundation Trust, London, United Kingdom., Aboubakar Nana F; Département de Pneumologie, Cliniques Universitaires St-Luc, Brussels, Belgium., Aujayeb A; Northumbria HealthCare National Health Service (NHS) Foundation Trust, Newcastle upon Tyne, United Kingdom., Cortellini A; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Newsom-Davis T; Department of Oncology, Chelsea and Westminster NHS Foundation Trust, London, United Kingdom., Camidge DR; University of Colorado Cancer Center, Aurora, Colorado., Vitzthum LK; Department of Radiation Oncology, Stanford University, Stanford, California., Cappuzzo F; IRCCS Regina Elena National Cancer Institute, Rome, Italy., Marron TU; Division of Hematology-Oncology, Department of Medicine, Tisch Cancer Institute, Mount Sinai Hospital, New York, New York., Lanuti M; Division of Thoracic Surgery, Massachusetts General Hospital, Boston, Massachusetts., Gainor JF; Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts., Kwiatkowski DJ; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Park HS; Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut., Owen D; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Keane FK; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.
Source: JTO clinical and research reports [JTO Clin Res Rep] 2025 Dec 29; Vol. 7 (4), pp. 100949. Date of Electronic Publication: 2025 Dec 29 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101769967 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3643 (Electronic) Linking ISSN: 26663643 NLM ISO Abbreviation: JTO Clin Res Rep Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-3643
DOI:10.1016/j.jtocrr.2025.100949